CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population.

about

Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer.Germline mutation of CHEK2 in neurofibromatosis 1 and 2: Two case reports.

P2860

Q47553036-DE91E9E2-AD98-4A8A-8829-00C08357DCE2 Q54976802-071A1652-B706-4C5F-9A33-13119BCE3275

P2860

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population.

Item

http://www.wikidata.org/entity/Q41611265

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

CHEK2 c.1100delC mutation is a ...... in Finnish patient population.

@en

type

Item

label

CHEK2 c.1100delC mutation is a ...... in Finnish patient population.

@en

prefLabel

CHEK2 c.1100delC mutation is a ...... in Finnish patient population.

@en

P1476

CHEK2 c.1100delC mutation is a ...... in Finnish patient population.

@en

P2093

Antti Jekunen

http://www.w3.org/2001/XMLSchema#string

Johanna Mattson

http://www.w3.org/2001/XMLSchema#string

Kristiina Aittomäki

http://www.w3.org/2001/XMLSchema#string

Liisa M Pelttari

http://www.w3.org/2001/XMLSchema#string

Paula Poikonen-Saksela

http://www.w3.org/2001/XMLSchema#string

Päivi Auvinen

http://www.w3.org/2001/XMLSchema#string

Sanna Hallamies

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Frequency of CHEK2*1100delC in New York breast cancer cases and controls

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

Germline mutations in RAD51D confer susceptibility to ovarian cancer

The CHEK2 gene and inherited breast cancer susceptibility

The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation.

A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer

Distribution and medical impact of loss-of-function variants in the Finnish founder population.

Breast-cancer risk in families with mutations in PALB2

Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer

P2888

s12885-017-3631-8

P304

620

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-017-3631-8

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kristiina Aittomäki

Heli Nevanlinna

Arja Jukkola-Vuorinen

Carl Blomqvist

P577

2017-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091486748

http://www.w3.org/2001/XMLSchema#string

P698

28874143

http://www.w3.org/2001/XMLSchema#string

P921

Finland

P932

5584025

http://www.w3.org/2001/XMLSchema#string

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population.

about

P2860

P2860

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932